Digirad has a beta of 1.0053. Let's try to break down what Digirad's beta means in this case. As returns on the market increase, Digirad returns are expected to increase less than the market. However, during the bear market, the loss on holding Digirad will be expected to be smaller as well. The beta indicator helps investors understand whether Digirad moves in the same direction as the rest of the market, and how volatile (i.e., risky) it is compared to the market (i.e., selected benchmark). In other words, if Digirad deviates very little from the market, it does not add much risk to the portfolio, but it also doesn't increase the expected returns.
How important is Star Equity's Liquidity
Star Equity
financial leverage refers to using borrowed capital as a funding source to finance Star Equity Holdings ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Star Equity financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Star Equity's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Star Equity's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Star Equity's total debt and its cash.
Breaking down Star Equity Indicators
The latest price surge of Digirad could raise concerns from shareholders as the firm it trading at a share price of
3.59 on very low momentum in volume. The company management teams may have good odds in positioning the firm resources to exploit market volatility in
February. The stock standard deviation of daily returns for 30 days investing horizon is currently 5.28. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Digirad partners.
Returns Breakdown
| Return on Assets | (0.0838) |
| Return on Equity | (0.22) |
| Return Capital | (0.0893) |
| Return on Sales | (0.0422) |
Our perspective of the latest Digirad surge
Standard deviation is down to 5.18. It may indicate a possible volatility dip. Digirad shows above-average downside volatility for the selected time horizon. We advise investors to inspect Digirad further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Digirad future alpha.
Our Conclusion on Digirad
Although some other entities under the medical devices industry are still a bit expensive, Digirad may offer a potential longer-term growth to shareholders. In closing, as of the 2nd of January 2021, our analysis shows that Digirad almost mirrors the market. The firm is
undervalued and projects
above average odds of financial turmoil for the next 2 years. Our ongoing 30 days buy-or-sell advice on the firm is
Strong Hold.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Ellen Johnson is a Member of Macroaxis Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Star Equity Holdings. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com